FDA warns websites marketing unapproved opioids

June 11, 2018

(HealthDay)—Nine online networks, operating 53 websites, have been warned that they must stop illegally marketing potentially dangerous, unapproved, and misbranded versions of opioid medications, according to the U.S. Food and Drug Administration.

As part of the effort to crack down on sales of illegal narcotics over the internet, a summit will be hosted with stakeholders to find new ways to collaborate and address these issues. In addition, the FDA will be taking action against companies whose websites break the law. Warning letters were sent to nine online networks; these will be followed by additional steps to prevent the flow of illegal, unapproved opioids.

Patients who buy from illegal online pharmacies may be putting their health at risk as these products could be counterfeit, contaminated, expired, or unsafe. In violation of the Federal Food, Drug, and Cosmetic Act, the websites offer opioids for sale that are misbranded and new drugs that are unapproved. The companies have been asked to respond within 10 working days, and are directed to inform the agency of specific actions taken.

"This illegal online marketing of unapproved opioids is contributing to the nation's crisis," FDA Commissioner Scott Gottlieb, M.D., said in a statement. "The new warning letters are part of a comprehensive campaign to target of unapproved opioids."

Explore further: FDA seizes counterfeit drugs, devices sold online

More information: More Information

Related Stories

FDA seizes counterfeit drugs, devices sold online

June 19, 2015
(HealthDay)—The U.S. Food and Drug Administration, along with international partners, moved this week against more than 1,050 websites that sell potentially dangerous counterfeit medicines and medical devices, the agency ...

FDA targets clinics offering unapproved stem cell therapies

May 11, 2018
(HealthDay)—The U.S. Food and Drug Administration has launched legal action to stop two stem cell clinics from providing unapproved treatments that have caused serious, long-term harm to some patients.

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

White House launches anti-opioid ad campaign aimed at youth

June 7, 2018
The White House launched a series of new advertisements Thursday aimed at warning young people about the dangers of opioids, taking another step in the effort to turn the tide against the deadly epidemic.

Canadian pharmacy fined $34 million for illegal imports

April 13, 2018
An online pharmacy that bills itself as Canada's largest was fined $34 million Friday for importing counterfeit cancer drugs and other unapproved pharmaceuticals into the United States, a sentence that one advocacy group ...

US cracks down on illegal diabetes remedies

July 23, 2013
(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online ...

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.